natgillin/translations-raw huggingface dataset:
Vaccination er ikke en erstatning for rutinemæssig screening for livmoderhalskræft.
Vaccination is not a substitute for routine cervical screening.
Vaccination gennem drikkevandet:
Vaccination via the drinking water:
Vaccination kan forårsage let temperaturforhøjelse (hyperthermi) (mindre end 1,5°C i højst 24 timer).
Vaccination may cause a slight hyperthermia (less than 1.5°C during a maximum period of 24 hours).
Vaccination kan normalt retfærdiggøres for individer, hvis primærvaccination er ufuldstændig (dvs. færre end tre doser er modtaget).
Vaccination is usually justified for individuals whose primary vaccination is incomplete (i.e. fewer than three doses have been received).
Vaccination kan undtagelsesvis forårsage hypersensitivitetsreaktioner.
Vaccination may exceptionally cause hypersensitivity reactions.
Vaccination kan undtagelsesvis forårsage overfølsomhedsreaktioner.
Vaccination may exceptionally cause hypersensitivity reactions.
Vaccination med Infanrix Penta bør udskydes, hvis barnet får pludselig høj feber.
Infanrix Penta should be postponed in infants with a severe sudden fever.
Vaccination med IXIARO kan som med andre vacciner muligvis ikke beskytte i alle tilfælde
As with any other vaccine, vaccination with IXIARO may not result in protection in all cases.
Vaccination med levende vacciner må derfor først gives tidligst 3 måneder efter, at hele den antileukæmiske behandling er afsluttet.
Vaccination with live vaccines should therefore be given 3 months at the earliest after termination of the entire antileukaemic treatment.
vaccination med levende virusvacciner
Immunisation with live virus vaccines
Vaccination med levende virusvacciner anbefales ikke i mindst 2 uger, inden behandling med BLINCYTO starter, under behandlingen, og indtil B-lymfocytterne er vendt tilbage til de normale værdier efter den sidste behandlingscyklus.
Vaccination with live virus vaccines is not recommended for at least 2 weeks prior to the start of BLINCYTO treatment, during treatment, and until recovery of B lymphocytes to normal ranges following last treatment cycle.
Vaccination med Nobilis IB 4-91 kan inducere milde respirationssymptomer, som kan vare i et par dage afhængigt af kyllingernes helbred og tilstand.
Vaccination with Nobilis IB 4-91 may induce mild respiratory signs which may persist for a few days depending on the health and condition of the chickens.
Vaccination med Nobilis IB 4-91 kan inducere milde, respiratoriske symptomer på sygdom, som kan vare i et par dage, afhængigt af kyllingernes helbred og tilstand.
Vaccination with Nobilis IB 4-91 may induce mild respiratory signs of disease which may persist for a few days depending on the health and condition of the chickens.
Vaccination med Nobivac Piro forhindrer ikke infektion.
Vaccination with Nobivac Piro does not prevent infection.
Vaccination med PROCOMVAX af spædbørn med moderat til svær pludselig feber bør udskydes, til de er blevet raske igen.
Vaccination with PROCOMVAX should be postponed in infants with moderate or severe sudden fever until they have recovered.
Vaccination med visse typer vaccine (levende, svækkede vacciner) under behandling med Tecfidera kan forårsage, at du får en infektion og skal derfor undgås.
Taking Tecfidera with certain types of vaccine (live vaccines) may cause you to get an infection and should therefore be avoided.
Vaccination mod distemper-, adeno-, parvo- og parainfluenza-virus (DHPPi):
Vaccination against distemper, adeno, parvo and parainfluenza virus (DHPPi):
Vaccination mod hepatitis A og B hos patienter, der regelmæssigt eller gentagne gange modtager humane plasma-afledte faktor X-produkter, kan være berettiget.
Vaccination against hepatitis A and B in patients who regularly or repeatedly receive human plasma- derived Factor X products may be warranted.
Vaccination skal udsættes hos personer med en alvorlig febersygdom eller akut infektion.
Vaccination should be postponed in individuals with a severe febrile illness or acute infection.
Vaccination to gange med 3-4 ugers mellemrum forhindrede, at der forblev FeLV i blodet, og forebyggede symptomerne på FeLV-infektion.
Vaccination on two occasions with three to four weeks between injections prevented FeLV from remaining in the blood and prevented the signs of FeLV infection.
Vaccination under behandling med Tecfidera er ikke undersøgt.
Vaccination during treatment with Tecfidera has not been studied.
Vaccinationen bør gentages hvert år med injektion af en enkelt "boosterdosis" for at opretholde
A ‘booster’ injection should be given every year to maintain the vaccine’s effect.
Vaccinationen bør udsættes hos personer, der for nyligt har haft høj feber.
Vaccination should be postponed in people with recent severe fever.
Vaccinationen kan forårsage en let forøgelse af dyrets kropstemperatur (mindre end 1,5°C i højst 24 timer).
Vaccination may cause a slight rise in the animal’s body temperature (less than 1.5°C during a maximum period of 24 hours).
Vaccinationen påvirkede ikke CD4% eller plasma- hiv-RNA.
The CD4% or plasma HIV RNA was not affected by vaccination.
Vaccinationen skal gives som intramuskulær injektion fortrinsvis i musculus deltoideus eller i det anterolaterale lår (afhængig af muskelmassen).
Immunisation should be carried out by intramuscular injection preferably into the deltoid muscle or anterolateral thigh (depending on the muscle mass).
Vaccinationen skal gives som intramuskulær injektion og helst i deltamusklen eller anterolateralt i låret, afhængig af muskelmassen.
Immunisation should be carried out by intramuscular injection preferably into the deltoid muscle or anterolateral thigh, depending on the muscle mass.
Vaccinationens virkning blev hovedsagelig bedømt ved dannelsen af beskyttende antistoffer hos børnene.
The main measure of effectiveness was the production of protective antibodies in the infants.
Vaccinationer med levende vacciner (som polio, mæslinger, fåresyge og røde hunde) anbefales ikke, da disse vacciner kan give dig en infektion, hvis du får dem, mens du tager Xaluprine.
Vaccination with live vaccines (like polio, measles, mumps and rubella) is not recommended, as these vaccines may give you an infection if you have them whilst you are taking Xaluprine.
Vaccinationer, mens du tager Xaluprine
Having vaccines while you are taking Xaluprine
Vaccinationer: hvis det er muligt skal dit barn føres ajour med alle vaccinationer, før behandling med Humira startes.
Vaccinations: if possible children should be up to date with all vaccinations before using Humira.
Vaccinationer: Hvis det er muligt, skal børn være ajour med alle vaccinationer, før du får Enbrel.
Vaccinations: If possible, children should be up to date with all vaccinations before using Enbrel.
Vaccinationer: hvis det er muligt, skal dit barn føres ajour med alle vaccinationer, før behandling med Humira startes.
Vaccinations: if possible children should be up to date with all vaccinations before using Humira.
Vaccinationer: hvis det er muligt, skal dit barn føres ajour med alle vaccinationer, før behandling med Humira startes.
Vaccinations: if possible your child should be up to date with all vaccinations before using Humira.
Vaccinationer: Nogle vacciner, som for eksempel oral poliovaccine, må ikke gives, mens man får Benepali.
Vaccinations: Some vaccines, such as oral polio vaccine, should not be given during Benepali therapy.
Vaccinationerne vil blive givet inden for 12 måneder.
The injections will be given within 12 months:
Vaccinationsforløb, der skal være afsluttet 6 uger inden behandling
Vaccination course to be completed 6 weeks before treatment
Vaccinationsplan
Vaccination scheme
Vaccinationsprogram
How much is given
Vaccinationsprogram
Vaccination programme
Vaccinationsprogram:
Primary vaccination course
Vaccinationsprogrammer for børn, som ikke er vaccineret ifølge det anbefalede vaccinations-program, bør afpasses individuelt.
Vaccination schedules for children not vaccinated according to the recommended schedule should be considered on an individual basis.
Vaccinationsprogrammet består af to injektionen med en dosis af 0,25 ml, der gives subkutant i nakken eller intramuskulært i brystet.
The vaccination scheme consists of two injections with a dose of 0.25 ml, administered subcutaneously in the neck or intramuscularly in the breast.
Vaccinationsprogrammet er tre doser PROCOMVAX, der helst skal gives ved to-, fire- og 12- til 15- måneders-alderen.
The vaccination schedule is three doses of PROCOMVAX, ideally at two, four, and 12 to 15 months of age.
Vaccinationsprogrammet for Synflorix afhænger af barnets alder og bør være baseret på officielle anbefalinger:
The vaccination schedule for Synflorix depends on the age of the child and should be based on official recommendations.
Vaccinationssvigt: PT “vaccinationssvigt”.
Vaccination failure: PT “Vaccination failure”.
Vaccinationssvigt: PT ”Vaccinationssvigt”.
Vaccination failure: PT “Vaccination failure”.
Vaccinationsudstyr skal bruges i henhold til producentens anvisninger.
Use vaccination devices according to the manufacturer’s instructions.
Vaccinationsudstyret bør anvendes i overensstemmelse med producentens vejledning.
Vaccines devices should be used in accordance with the device instructions provided by the manufacturer.
Vaccinationsudstyret skal avendes ifølge producentens vejledning.
Use vaccination devices according to the manufacturer’s instructions.
vaccine
HVT+IBD
vaccine
of vaccine
vaccine (levende) mod mæslinger, fåresyge og røde hunde
measles, mumps and rubella vaccine (live)
Vaccine etiket
Label of the vaccine
Vaccine indeholdende hepatitis A (inaktiveret) og hepatitis B (rDNA) (HAB), adsorberet
Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
Vaccine mod Babesia canis.
Vaccine against Babesia canis.
Vaccine mod bluetonguevirus (som indeholder en af serotyperne 1, 4 eller 8) (inaktiverede)
Bluetongue disease virus vaccine (containing either serotypes 1 , 4 or 8) (inactivated)
Vaccine mod bluetonguevirus, serotype 8
Bluetongue Virus Serotype 8 vaccine
Vaccine mod E. coli og C. perfringens infektioner
Vaccine against E. coli and C. perfringens infections
Vaccine mod fravænningsdiarré hos svin (levende)
E. coli O8:K87 vaccine (live)
Vaccine mod gul feber: risiko for dødelig generaliseret vaccinefremkaldt sygdom.
Yellow fever vaccine: risk of fatal generalized vaccine-induced disease.
Vaccine mod Klassisk Svinepest
Vaccine against Classical Swine Fever
Vaccine mod kolera (inaktiveret, oral)
Cholera vaccine (inactivated, oral)
Vaccine mod leptospirose.
Vaccine against leptospirosis.
Vaccine mod porcint circovirus og porcin enzootisk pneumoni (inaktiveret)
Porcine circovirus and porcine enzootic pneumonia vaccine (inactivated)
Vaccine mod progressiv atrofisk rhinitis.
Vaccine against progressive atrophic rhinitis.
Vaccine stammen kan findes i leveren i mindst 35 dage.
The vaccine strain can be found in the spleen for at least 35 days.
Vaccine, der er blevet trukket op i injektionssprøjten, skal opnå stuetemperatur før administration.
Prior to administration, the withdrawn vaccine should be allowed reach room temperature.
Vaccine, der er blevet trukket op i injektionssprøjten, skal opnå stuetemperatur før brug.
Prior to administration, the withdrawn vaccine should be allowed to reach room temperature.
Vaccine- effekt
Vaccine efficacy
Vaccine- serotype IPD(1)
Serotype 6B IPD
Vaccine: Kulturmedium.
Vaccine: culture medium
Vaccine: Opbevares i køleskab (2C - 8C).
Vaccine: Store in a refrigerator (2 C – 8 C).
Vaccinedosis
Vaccine Dose
Vaccineeffekt
Vaccine efficacy
Vaccineeffekten mod det første tilfælde af klinisk AOM var dog 19 % i TV-kohorten (95 % CI 4,4; 31,4).
However, in TVC cohort, vaccine efficacy against first clinical AOM episode was 19% (95% CI: 4.4; 31.4).
VACCINEETIKET
Lyophilisate vial
Vaccinen anvendes ikke til at behandle HPV- relaterede sygdomme.
The vaccine is not used to treat HPV related diseases.
Vaccinen anvendes til at forebygge viræmi (tilstedeværelse af virus i blodet) og reducere kliniske symptomer forårsaget af bluetonguevirus hos får og til at forebygge viræmi hos kvæg.
The vaccine is used to prevent viraemia (the presence of viruses in the blood) and to reduce clinical signs caused by bluetongue virus in sheep and to prevent viraemia in cattle.
Vaccinen anvendes til at reducere antallet af heste med Vest-Nil–virus, oprindelse 1 eller 2 i blodet (viræmi) og til at reducere sværhedsgraden og varigheden af de kliniske tegn på Vest-Nil-virussygdommen forårsaget af oprindelse 2-stammer.
The vaccine is used to reduce the number of horses with the West Nile virus lineage 1 or 2 in their blood (viraemia) and to reduce the severity and duration of clinical signs of West Nile virus disease caused by lineage 2 strains.
Vaccinen beskytter ikke mod hepatitis A, hepatitis C og hepatitis E eller andre patogener, der inficerer leveren.
The vaccine will not prevent infection caused by other agents such as hepatitis A, hepatitis C and hepatitis E and other pathogens known to infect the liver.
Vaccinen bliver desuden bundet til overfladen (adsorberet) af en aluminiumholdig forbindelse for at forstærke immunresponsen.
The vaccine is also ‘adsorbed’ (fixed) onto an aluminium compound to stimulate a better response.
Vaccinen bruges til voksne (18-60 år) og ældre (over 60 år) for at forebygge influenza af virustypen H5N1.
It has to be used in adults (from 18 to 60 years old) and elderly (over 60 years) to prevent flu caused by the H5N1 type of the virus.
Vaccinen bør administreres straks efter anbrud.
After first opening, immediate use is recommended.
Vaccinen bør bruges straks efter udtag fra hætteglasset.
After first opening, immediate use is recommended.
Vaccinen bør ikke håndteres af mennesker med et svagt immunsystem.
The vaccine should not be handled by people with a weak immune system.
Vaccinen bør inspiceres visuelt for tilstedeværelsen af partikler og misfarvning forud for indgivelse.
The vaccine should be inspected visually in order to detect any appearance of precipitate or discolouring of the content prior to administration.
Vaccinen bør opløses umiddelbart efter den er taget ud af køleskab (eller anden kold opbevaring).
Reconstitute immediately after removal from the refrigerator (or other cold storage).
Vaccinen er "adsorberet".
The vaccine is ‘adsorbed’.
Vaccinen er adsorberet.
The vaccine is ‘adsorbed’.
Vaccinen er beregnet til aktiv immunisering af raske hvalpe og hunde mod sygdomme forårsaget af hundesygevirus, hundeparvovirus, hundeadenovirus type 1 og 2, hundeparainfluenzavirus, Leptospira interrogans serogruppe Australis serovar Bratislava, Leptospira interrogans serogruppe Canicola servar Canicola, Leptospira kirschneri serogruppe Grippotyphosa serovar Grippotyphosa og Leptospira interrogans serogruppe Icterohaemorrhagiae serovar Icterohaemorrhagiae
The vaccine is intended for the active immunisation of healthy puppies and dogs against diseases caused by canine distemper virus, canine parvovirus, canine adenovirus type 1 and 2, canine parainfluenza virus, Leptospira interrogans serogroup Australis serovar Bratislava, Leptospira interrogans serogroup Canicola servar Canicola, Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa and Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagaie.
Vaccinen er beregnet til aktiv immunisering af raske hvalpe og hunde mod sygdomme forårsaget af hundesygevirus, hundeparvovirus, hundeadenovirus type 1 og 2, hundeparainfluenzavirus, Leptospira interrogans serogruppe Australis serovar Bratislava, Leptospira interrogans serogruppe Canicola servar Canicola, Leptospira kirschneri serogruppe Grippotyphosa serovar Grippotyphosa og Leptospira interrogans serogruppe Icterohaemorrhagiae serovar Icterohaemorrhagiae samt rabiesvirus.
The vaccine is intended for the active immunisation of healthy puppies and dogs against diseases caused by canine distemper virus, canine parvovirus, canine adenovirus type 1 and 2, canine parainfluenza virus, Leptospira interrogans serogroup Australis serovar Bratislava, Leptospira interrogans serogroup Canicola servar Canicola, Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa, Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagaie, and rabies virus.
Vaccinen er beregnet til aktiv immunisering af raske hvalpe og hunde mod sygdomme forårsaget af hundesygevirus, hundeparvovirus, hundeadenovirus type 1 og 2, hundeparainfluenzavirus, Leptospira interrogans serogruppe Australis serovar Bratislava, Leptospira interrogans serogruppe Canicola servar Canicola, Leptospira kirschneri serogruppe Grippotyphosa serovar Grippotyphosa og Leptospira interrogans serogruppe Icterohaemorrhagiae serovar Icterohaemorrhagiae.
The vaccine is intended for the active immunisation of healthy puppies and dogs against diseases caused by canine parainfluenza virus, Leptospira interrogans serogroup Australis serovar Bratislava, Leptospira interrogans serogroup Canicola serovar Canicola, Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa and Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagaie.
Vaccinen er beregnet til aktiv immunisering af raske hvalpe og hunde mod sygdomme forårsaget af Leptospira interrogans serogruppe Australis serovar Bratislava, Leptospira interrogans serogruppe Canicola servar Canicola, Leptospira kirschneri serogruppe Grippotyphosa serovar Grippotyphosa og Leptospira interrogans serogruppe Icterohaemorrhagiae serovar Icterohaemorrhagiae.
The vaccine is intended for the active immunisation of healthy puppies and dogs against diseases caused by Leptospira interrogans serogroup Australis serovar Bratislava, Leptospira interrogans serogroup Canicola serovar Canicola, Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa and Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagaie.
Vaccinen er blevet godkendt under ‘særlige omstændigheder’.
The vaccine has been authorised under ‘exceptional circumstances’.
Vaccinen er blevet godkendt under ”særlige omstændigheder”.
The vaccine has been authorised under ‘exceptional circumstances’.
Vaccinen er blevet udviklet, så den kan anvendes før eller under en influenzapandemi til beskyttelse mod denne H5N1- virus.
The vaccine has been developed so that it can be used before or during a flu pandemic to provide protection against the H5N1 virus.
Vaccinen er en celleassocieret levende, rekombinant kalkunherpesvirus (HVT), der udviser gD- og gI- glycoproteiner over for infektiøs laryngotracheitis-virus.
The vaccine is a cell-associated live recombinant turkey herpesvirus (HVT) expressing the gD and gI glycoproteins of infectious laryngotracheitis virus.
Vaccinen er en hvid suspension til indsprøjtning, som leveres i en fyldt enkeltdosis-injektionssprøjte (0,5 ml).
The vaccine is a white suspension for injection, provided in a single-dose, pre-filled syringe (0.5 ml).
Vaccinen er en hvidlig opslæmning (suspension), der leveres i en flaske med en enkelt dosis.
The vaccine is a whitish suspension supplied in a single-dose glass bottle.
Vaccinen er en hvidlig suspension i en flaske.
The vaccine is a whitish suspension supplied in a bottle.
Vaccinen er en klar til opaliserende suspension.
The vaccine is a clear to opalescent suspension.
Vaccinen er en levende rekombinant E2 gen-deleteret bovin viral diarré virus indeholdende klassisk svinefeber E2.
The vaccine is a live recombinant E2 gene deleted Bovine Viral Diarrhoea Virus containing Classical Swine Fever E2.
Vaccinen er en suspension til injektion og leveres i en enkeltdosis fyldt injektionssprøjte (0,5 ml).
The vaccine is a suspension for injection and provided in a single-dose pre-filled syringe (0.5 ml).
Vaccinen er endvidere effektiv mod Marek’s sygdom.
The vaccine is also effective against Marek’s disease.
Vaccinen er i overensstemmelse med WHO's anbefaling og EU's beslutning vedr. pandemien.
This vaccine complies with the WHO recommendation and EU decision for the pandemic.
Vaccinen er i stand til at frembringe antistoffer i et bredt udsnit af fuglearter.
The vaccine is able to induce antibodies in a wide range of birds.
Vaccinen er ikke undersøgt hos personer med svækket immunitet.
The vaccine has not been studied in subjects with impaired immunity.
Vaccinen er imidlertid vist også at være sikker i et feltstudie, der omfattede 2 måneder gamle dyr.
However the vaccine has also been shown to be safe in a field study including animals of 2 months of age.
Vaccinen er klar til brug – du skal ikke blande den med noget.
It is ready to use - you do not need to mix it with anything.
Vaccinen er kun til intramuskulær anvendelse.
The vaccine is for intramuscular use only.
Vaccinen er med til at lindre sygdommenes symptomer og reducere udskillelsen af virus ved infektion med calicivirus.
The vaccine helps to reduce the symptoms of the diseases and helps to reduce viral excretion in case of calicivirus infection.
Vaccinen er også "adsorberet" (bundet til overfladen) af en aluminiumholdig forbindelse, hvorved immunreaktionen forstærkes.
The vaccine is also ‘adsorbed’ (fixed) onto an aluminium compound to enhance the immune response.
Vaccinen er rettet mod tre influenzavirusstammer efter Verdenssundhedsorganisationens (WHO’s) anbefalinger for sæsonen 2015/2016.
The vaccine targets three strains of influenza virus following the recommendations by the World Health Organisation for the 2015/2016 season.
Vaccinen er sikker til inficeredehunde.
The vaccine is safe in infected dogs.
Vaccinen er testet for sikkerhed i kyllinger og nogle støttende data er tilgængelige om sikkerhed i ænder.
This vaccine has been tested for safety in chickens. and some supportive data for safety in ducks are available.
Vaccinen er »adsorberet«, hvilket betyder, at de viruslignende partikler og MPL er bundet til en aluminiumholdig forbindelse, hvorved immunresponsen forbedres.
The vaccine is ‘adsorbed’, which means that the virus-like particles and the MPL are fixed onto an aluminium compound, to stimulate a better immune response.
Vaccinen er ”adsorberet”.
The vaccine is ‘adsorbed’.
Vaccinen forventes kun at beskytte mod influenza forårsaget af A/California/07/2009 (H1N1)v- lignende stammer.
The vaccine can only be expected to protect against influenza caused by A/California/07/2009 (H1N1)v- like strains.
Vaccinen fremstilles ved hjælp af et "adjuverende system", der indeholder MPL, en oprenset væske (en fedtlignende substans) udvundet af bakterier, som øger immunsystemets respons på vaccinen.
The vaccine is made using an ‘adjuvant system’ that contains MPL, a purified lipid (a fat-like substance) extracted from bacteria, which enhances the response of the immune system to the vaccine.
Vaccinen fås som injektionsvæske, opløsning.
It is available as a solution for injection.
Vaccinen fører til dannelse af aktiv immunitet hos kommende æglæggere (broiler breeders) og derved opnåelse af passiv immunitet hos afkommet mod Ornithobacterium rhinotracheale serotype A.
The vaccine is to stimulate active immunity in broiler breeders in order to provide passive immunity to the progeny against Ornithobacterium rhinotracheale serotype A.
Vaccinen fører til dannelse af aktiv immunitet hos kommende æglæggere (broiler breeders) og derved opnås passiv immunitet hos afkommet mod Ornithobacterium rhinotracheale serotype A.
The vaccine is to stimulate active immunity in broiler breeders in order to provide passive immunity to the progeny against Ornithobacterium rhinotracheale serotype A .
Vaccinen giver muligvis ikke beskyttelse mod hepatitis B i sådanne tilfælde.
The vaccine may not prevent hepatitis B in these individuals.
Vaccinen gives fra sprøjtens spids ind i næseborsåbningen indtil den når næsehulen mens katten trækker vejret ind.
The vaccine is administered directly from the tip of the syringe onto the opening of the nostril and enters the nasal cavity during inhalation.
Vaccinen gives i overensstemmelse med de officielle anbefalinger.
The vaccine should be given according to official recommendations.
Vaccinen gives intramuskulært (IM) eller subkutant (SC).
The vaccine is to be injected intramuscularly (IM) or subcutaneously (SC).
Vaccinen gives til hundyrene før og/eller under drægtighedsperioden.
The vaccine is given to female pigs before and/or during pregnancy.